MMED — Minimed Cashflow Statement
0.000.00%
Last trade - 00:00- $4.05bn
- $4.05bn
- $2.47bn
Annual cashflow statement for Minimed, fiscal year end - April 26th, USD millions except per share, conversion factor applied.
2023 April 28th | 2024 April 26th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -92 | -107 |
| Depreciation | ||
| Deferred Taxes | ||
| Non-Cash Items | 74 | 89 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -92 | -73 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Payable / Accrued Expenses | ||
| Net Change in Other Assets & Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -6 | 41 |
| Capital Expenditures | -167 | -148 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -13 | -9 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -180 | -157 |
| Financing Cash Flow Items | 185 | 112 |
| Other Financing Cash Flow | ||
| Cash from Financing Activities | 185 | 112 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -1 | -4 |